RecruitingAccepts healthy volunteers
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
Salus University · NCT07282691
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 150
- US sites recruiting
- 1
- Study start
- April 1, 2025
- Record last updated
- December 15, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Conditions: MTBI - Mild Traumatic Brain Injury
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosis of mTBI within previous 1 to 6 months
- Distance visual acuity better than or equal to 20/25 in each eye
- Score >21 on Convergence Insufficiency Symptom Survey
Exclusion Criteria
- Diagnosis of moderate or severe TBI; > 30-min loss of consciousness
- Not wearing required refractive error)
- Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
- Cognitive delays that may impact testing
Recruiting US locations
The Eye Institute
Philadelphia, PA 19141
Study contacts (from the official record)
- Katie Holmbeck, BS · 2157801429 · kh3482@drexel.edu
- Mitchell Scheiman, OD, PhD · 2157801427 · ms5758@drexel.edu
Similar studies in Pennsylvania
All neurology studies in Pennsylvania →- RecruitingPhase 1/Phase 2Overnight stay mentioned
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Vector Y Therapeutics
- Location
- Philadelphia, PA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
University of Pennsylvania
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingHealthy volunteersEarly Phase 1
Localizing Epileptic Networks Using MRI and iEEG
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 40–80